SEARCH

SEARCH BY CITATION

References

  • ADKINS, C.E., PILLAI, G.V., KERBY, J., BONNERT, T.P., HALDON, C., MCKERNAN, R.M., GONZALEZ, J.E., OADES, K., WHITING, P.J. & SIMPSON, P.B. (2001). α4β3δ GABAA receptors characterized by fluorescence resonance energy transfer-derived measurements of membrane potential. J. Biol. Chem., 276, 3893438939.
  • AINSCOUGH, E.W., BRODIE, A.M., DENNY, W.A., FINLAY, G.J., GOTHE, S.A. & RANFORD, J.D. (1999). Cytotoxicity of salicylaldehyde benzoylhydrazone analogs and their transition metal complexes: quantitative structure–activity relationships. J. Inorg. Biochem., 77, 125133.
  • BARISH, M.E. (1983). A transient calcium-dependent chloride current in the immature Xenopus oocyte. J. Physiol. (Lond)., 342, 309325.
  • BELELLI, D., LAMBERT, J.J., PETERS, J.A., WAFFORD, K. & WHITING, P.J. (1997). The interaction of the general anesthetic etomidate with the gamma-aminobutyric acid type A receptor is influenced by a single amino acid. Proc. Natl. Acad. Sci. U.S.A., 94, 1103111036.
  • BERA, A.K., CHATAV, M. & AKABAS, M.H. (2002). GABAA receptor M2–M3 loop secondary structure and changes in accessibility during channel gating. J. Biol. Chem., 277, 4300243010.
  • BLANTON, M.P. & COHEN, J.B. (1994). Identifying the lipid–protein interface of the Torpedo nicotinic acetylcholine receptor: secondary structure implications. Biochemistry, 33, 28592872.
  • BROWN, N., KERBY, J., BONNERT, T.P., WHITING, P.J. & WAFFORD, K.A. (2002). Pharmacological characterization of a novel cell line expressing human α4β3δ GABAA receptors. Br. J. Pharmacol., 136, 965974.
  • CHANG, Y., WANG, R., BAROT, S. & WEISS, D.S. (1996). Stoichiometry of a recombinant GABAA receptor. J. Neurosci., 16, 54155424.
  • FARRAR, S.J., WHITING, P.J., BONNERT, T.P. & MCKERNAN, R.M. (1999). Stoichiometry of a ligand-gated ion channel determined by fluorescence energy transfer. J. Biol. Chem., 274, 1010010104.
  • HADINGHAM, K.L., WINGROVE, P., LE BOURDELLES, B., PALMER, K.J., RAGAN, C.I. & WAFFORD, K.A. (1993a). Cloning of cDNA sequences encoding human α1 and α3 γ-aminobutyric acidA receptor subunits and characterization of the benzodiazepine pharmacology of recombinant α1-, α2-, α3-, and α5-containing human γ-aminobutyric acidA receptors. Mol. Pharmacol., 43, 970975.
  • HADINGHAM, K.L., WINGROVE, P.B., WAFFORD, K.A., BAIN, C., KEMP, J.A., PALMER, K.J., WILSON, A.W., WILCOX, A.S., SIKELA, J.M., RAGAN, C.I. & WHITING, P.J. (1993b). Role of the β subunit in determining the pharmacology of human γ-aminobutyric acid type A receptors. Mol. Pharmacol., 44, 12111218.
  • HALLIWELL, R.F., THOMAS, P., PATTEN, D., JAMES, C.H., MARTINEZ-TORRES, A., MILEDI, R. & SMART, T.G. (1999). Subunit-selective modulation of GABAA receptors by the non-steroid anti-inflammatory agent, mefenamic acid. Eur. J. Neurosci., 11, 28972905.
  • HILL-VENNING, C., BELELLI, D., PETERS, J.A. & LAMBERT, J.J. (1997). Subunit-dependent interaction of the general anaesthetic etomidate with the γ-aminobutyric acid type A receptor. Br. J. Pharmacol., 120, 749756.
  • KORPI, E.R., GRUNDER, G. & LÜDDENS, H. (2002). Drug interactions at GABA(A) receptors. Prog. Neurobiol., 67, 113159.
  • JURD, R., ARRAS, M., LAMBERT, S., DREXLER, B., SIEGWART, R., CRESTANI, F., ZAUGG, M., VOGT, K.E., LEDERMANN, B., ANTKOWIAK, B. & RUDOLPH, U. (2003). General anesthetic actions in vivo strongly attenuated by a point mutation in the GABAA receptor β3 subunit. FASEB J., 17, 250252.
  • PIRKER, S., SCHWARZER, C., WIESELTHALER, A., SIEGHART, W. & SPERK, G. (2000). GABAA receptors: immunocytochemical distribution of 13 subunits in the adult rat brain. Neuroscience, 101, 815850.
  • PISTIS, M., BELELLI, D., MCGURK, K., PETERS, J.A. & LAMBERT, J.J. (1999). Complementary regulation of anaesthetic activation of human (α6β3γ2L) and Drosophila (RDL) GABA receptors by a single amino acid residue. J. Physiol., 515, 318.
  • REYNOLDS, D.S., ROSAHL, T.W., CIRONE, J., O'MEARA, G.F., HAYTHORNTHWAITE, A., NEWMAN, R.J., MYERS, J., SUR, C., HOWELL, O., RUTTER, A.R., ATACK, J., MACAULAY, A.J., HADINGHAM, K.L., HUTSON, P.H., BELELLI, D., LAMBERT, J.J., DAWSON, G.R., MCKERNAN, R., WHITING, P.J. & WAFFORD, K.A. (2003). Sedation and anesthesia mediated by distinct GABAA receptor isoforms. J. Neurosci., 23, 86088617.
  • SIEGHART, W. & SPERK, G. (2002). Subunit composition, distribution and function of GABAA receptor subtypes. Curr. Top. Med. Chem., 2, 795816.
  • SMITH, A.J. & SIMPSON, P.B. (2003). Methodological approaches for the study of GABAA receptor pharmacology and functional responses. Anal. Bioanal. Chem., 377, 843851.
  • THOMPSON, S.A., ARDEN, S.A., MARSHALL, G., WINGROVE, P.B., WHITING, P.J. & WAFFORD, K.A. (1999). Residues in transmembrane domains I and II determine γ-aminobutyric acid type A receptor subtype-selective antagonism by furosemide. Mol. Pharmacol., 55, 993999.
  • THOMPSON, S.A., WHITING, P.J. & WAFFORD, K.A. (1996). Barbiturate interactions at the human GABAA receptor: dependence on receptor subunit combination. Br. J. Pharmacol., 117, 521527.
  • THOMPSON, S.A., WINGROVE, P.B., CONNELLY, L., WHITING, P.J. & WAFFORD, K.A. (2002). Tracazolate reveals a novel type of allosteric interaction with recombinant gamma-aminobutyric acid(A) receptors. Mol. Pharmacol., 61, 861869.
  • WAFFORD, K.A., BAIN, C.J., QUIRK, K., MCKERNAN, R.M., WINGROVE, P.B., WHITING, P.J. & KEMP, J.A. (1994). A novel allosteric modulatory site on the GABAA receptor β subunit. Neuron, 12, 775782.
  • WHITE, G., GURLEY, D., HARTNETT, C., STIRLING, V. & GREGORY, J. (1995). Human α and β subunits contribute to the EC50 for GABA at the GABAA receptor expressed in Xenopus oocytes. Receptors Channels, 3, 15.
  • WHITING, P.J. (2003). GABA-A receptor subtypes in the brain: a paradigm for CNS drug discovery? Drug Discov. Today, 8, 445450.
  • WHITING, P.J., WAFFORD, K.A., PRIBILLA, I. & PETRI, T. (1995). Channel cloning, mutagenesis, and expression. In: Ion Channels. A Practical Approach, ed. Ashley, R.H. pp. 133169. McLean, VA: IRL Press.
  • WILKINS, M.E. & SMART, T.G. (2002). Redox modulation of GABAA receptors obscured by Zn2+ complexation. Neuropharmacology, 43, 938944.
  • WINGROVE, P.B., WAFFORD, K.A., BAIN, C. & WHITING, P.J. (1994). The modulatory action of loreclezole at the γ-aminobutyric acid type A receptor is determined by a single amino acid in the β2 and β3 subunit. Proc. Natl. Acad. Sci. U.S.A., 91, 45694573.